Skip to main content

Table 1 Demographic and clinical variables of the 26 study patients

From: IGF-1 in autosomal dominant cerebellar ataxia - open-label trial

Patients(N) Age (average ± SD) (rank) Gender (M/F,%) (N) Age at onset (average ± SD) (rank) Disease duration (years) (average ± SD) (rank) Expanded CAG repeats (average ± SD) (rank) Baseline SARA (average ± SD) (rank)
SCA3 (19) 50.32 ± 13.60 (28 – 74) 68.4/31.6 (13/6) 40.53 ± 12.19 (20 – 62) 9.84 ± 7.41 (2 – 30) 47.3 ± 33.5 (52 – 75) 11.89 ± 4.82 (8 – 28)
SCA7 (6) 45.71 ± 16.86 (28 – 66) 71.4/28.6 (5/2) 34.71 ± 10.87 (23 – 48) 11.00 ± 6.02 (4 – 18) 43.3 ± 24.3 (34 – 50) 16.19 ± 6.32 (8–27)
SCA6 (1) 55 100/0 48 7 23 14
Total (26) 49.30 ± 14.12 (28–74) 70.37/29.63 (19/8) 39.3 ± 11.83 (20 – 62) 10.04 ± 6.92 (2 – 30) 13.17 ± 5.38 (8 – 28)
  1. N number.